Merus Ownership | Who Owns Merus?
Merus Ownership Summary
Merus is owned by 102.64% institutional investors, 1.85% insiders. Fmr is the largest institutional shareholder, holding 10.11% of MRUS shares. Vanguard Health Care Inv is the top mutual fund, with 3.44% of its assets in Merus shares.
MRUS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Merus | 102.64% | 1.85% | -4.49% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 6.90M | 10.11% | $290.12M |
| Rtw investments, lp | 4.17M | 6.11% | $175.32M |
| Commodore capital lp | 3.87M | 5.68% | $162.91M |
| Wellington management group llp | 3.50M | 5.12% | $147.08M |
| Deerfield management company, l.p. (series c) | 2.97M | 4.36% | $125.01M |
| Samlyn capital | 2.67M | 3.91% | $112.20M |
| Boxer capital | 1.90M | 3.27% | $112.42M |
| Avoro capital advisors | 2.13M | 3.11% | $89.36M |
| Franklin resources | 1.98M | 2.91% | $83.45M |
| Holocene advisors, lp | 1.88M | 2.75% | $79.05M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lynx1 capital management lp | 1.58M | 24.92% | $66.47M |
| Commodore capital lp | 3.87M | 11.94% | $162.91M |
| Artia global partners lp | 463.84K | 6.97% | $19.50M |
| Stempoint capital lp | 614.81K | 6.45% | $25.85M |
| Silverarc capital management | 680.85K | 6.26% | $28.63M |
| Boxer capital | 1.90M | 5.92% | $112.42M |
| Dafna capital management | 451.80K | 4.83% | $19.00M |
| Nan fung group | 120.04K | 4.32% | $5.05M |
| Ally bridge group (ny) | 116.80K | 4.21% | $4.91M |
| Saturn v capital management | 234.64K | 3.86% | $9.87M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 1.11M | 0.01% | 1.10M |
| Avoro capital advisors | 2.13M | 1.26% | 770.00K |
| Wellington management group llp | 3.50M | 0.03% | 610.14K |
| Commodore capital lp | 3.87M | 11.94% | 524.18K |
| Morgan stanley | 1.50M | 0.01% | 523.79K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bvf inc/il | - | - | -1.28M |
| Medicxi ventures management (jersey) | - | - | -1.17M |
| Paradigm biocapital advisors lp | 1.69M | 2.47% | -765.00K |
| Logos global management lp | - | - | -750.00K |
| Lord, abbett | - | - | -723.99K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Gilead sciences | 452.53K | 1.23% | 452.53K | $19.03M |
| Octagon capital advisors lp | 308.00K | 2.13% | 308.00K | $12.95M |
| Caligan partners lp | 255.00K | 2.72% | 255.00K | $10.72M |
| Impax asset management group | 180.00K | 0.03% | 180.00K | $7.57M |
| Alyeska investment group | 136.36K | 0.02% | 136.36K | $5.73M |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -4.00 |
| Twin tree management, lp | -6.00 |
| Global retirement partners | -14.00 |
| Skopos labs | -34.00 |
| Creative planning | -77.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 194 | -3.00% | 70,836,485 | 0.66% | 102 | 0.97% | 97 | -11.01% | 63 | 18.87% |
| Dec 31, 2024 | 197 | 0.51% | 69,971,572 | 1.37% | 102 | 1.00% | 107 | 2.88% | 54 | 5.88% |
| Sep 30, 2024 | 195 | 4.84% | 69,020,442 | 3.79% | 101 | 0.77% | 104 | -15.45% | 51 | 21.43% |
| Jun 30, 2024 | 185 | 12.80% | 66,502,612 | 29.82% | 114 | 1.16% | 123 | 43.02% | 42 | -19.23% |
| Mar 31, 2024 | 164 | 21.48% | 51,225,619 | 0.09% | 99 | 1.10% | 86 | 17.81% | 52 | 33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 2.38M | 3.44% | 797.38K |
| Fidelity Select Health Care | 1.19M | 1.72% | 87.10K |
| Polar Capital Healthcare Opports Inc | 948.58K | 1.37% | - |
| HBM Healthcare Investments AG Ord | 917.41K | 1.33% | 62.21K |
| Franklin Biotechnology Discv A(acc)USD | 870.48K | 1.26% | - |
| Fidelity Select Biotechnology | 856.75K | 1.24% | -18.20K |
| Strategic Advisers Fidelity US TtlStk | 741.45K | 1.07% | 26.91K |
| Federated Hermes Kaufmann Small Cap A | 707.29K | 1.02% | -234.20K |
| Federated Hermes Kaufmann Small Cap Grow | 707.29K | 1.02% | -234.20K |
| Fidelity Advisor Health Care I | 696.08K | 1.01% | 24.28K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 21, 2025 | Shuman Harry | VP Controller, PAO | Sell | $48.55K |
| Mar 21, 2025 | Shuman Harry | VP Controller, PAO | Sell | $145.44K |
| Aug 21, 2024 | Shuman Harry | VP Controller, PAO | Sell | $135.00K |
| Jun 27, 2024 | Silverman Peter B. | COO & GC | Sell | $600.00K |
| Jun 17, 2024 | Silverman Peter B. | COO & GC | Sell | $3.50M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | 6 |
| 2023 Q4 | - | 4 |
| 2023 Q2 | - | 1 |
MRUS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools